Balyasny Asset Management LLC Seagen Inc. Put Options Transaction History

Balyasny Asset Management LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $24.9 Million - $28.1 Million	130,000 Added 21.85%	725,000 $154 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $112 Million - $123 Million	595,000 New	595,000 $115 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $4.35 Million - $7.17 Million	40,000 New	40,000 $7.08 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.